Journal of the Pancreas Open Access

  • ISSN: 1590-8577
  • Journal h-index: 80
  • Journal CiteScore: 29.12
  • Journal Impact Factor: 19.45*
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Abstract

The Effect of a Pancreatic Anastomosis Leak on Survival Following Pancreaticoduodenectomy for Ampullary, Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma

Avinash Sewpaul, Yasser Farooque, Stuart Robinson, Gourab Sen, Jeremy Jules French, Steven White, Derek Manas, Richard Charnley, Bryon Jaques

Objective Pancreatic leak following pancreaticoduodenectomy has a major impact on postoperative morbidity. There is however, very little data on the impact of a pancreatic leak on long-term survival following pancreaticoduodenectomy for cancer. The aim of this study was to analyse the impact of pancreatic leak/post-operative pancreatic fistula on survival in patients who underwent a pancreaticoduodenectomy for ampullary, distal cholangiocarcinoma or pancreatic ductal adenocarcinoma. Methods Prospectively collected data from 451 patients undergoing pancreaticoduodenectomy resections from 01 January 2002 - 31 December 2013 were examined. The survival of patients with and without leaks were compared using Kaplan-Meier curves and significance was measured using log-rank (Mantel-Cox). Other well-known prognostic factors after resection for the 3 histological subgroups were also investigated. Results 94 of the 451 patients had a post-operative pancreatic fistula giving an overall pancreatic anastomotic leak rate of 20.8%. The median follow-up was 23 months. A pancreatic leak/post-operative pancreatic fistula did not appear to have a detrimental effect on survival as demonstrated by Kaplan Meir survival curves in all of the 3 histological subgroups. Conclusion Our study seems to corroborate the findings of others, in that a postoperative pancreatic fistula does not seem to have a negative impact on patients’ long-term survival. This appears to apply not only to pancreatic ductal cancers, but also to ampullary adenocarcinomas and distal cholangiocarcinomas.